Imugene and City of Hope doses first subject in Phase I solid tumour trial
Imugene and City of Hope have dosed first subject in Phase I trial of a cancer-killing virus, CF33-hNIS (Vaxinia), in solid tumour patients.
Source: clinicaltrialsarena.com
Page 6 - Centric Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Centric Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Centric Services Today - Breaking & Trending Today
Hepatitis C accounts for 0.9% share of global Infectious Disease clinical trial activity in 2021
Methodology:The clinical trials data used for the analyses were extracted from the Clinical Trials Database of GlobalDataâs Pharma Intelligence Center. Clinical Trials are sourced from numerous government, non-government and company clinical trial registries worldwide alongside clinical research publications, scientific conferences, company websites, SEC filings and more. The information is gathered by a combination of automation and secondary research to ensure accuracy and validity. A small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, ...
Source: clinicaltrialsarena.com
Sen-Jam initiates subject enrolment in Phase II Covid-19 treatment trial
Sen-Jam Pharmaceutical has initiated subject enrolment in the Phase II trial of its investigational oral Covid-19 therapy, SJP-002C, in Nepal.
Source: clinicaltrialsarena.com
CNS to commence trial of Berubicin for glioblastoma multiforme
CNS Pharmaceuticals is set to commence its pivotal trial of Berubicin to treat recurrent glioblastoma multiforme (GBM).
Source: clinicaltrialsarena.com
Skye retains CMAX Clinical Research for Phase I glaucoma treatment trial
Skye Bioscience has retained CMAX clinical Research for Phase I trial of its SBI-100 OE being developed for potential treatment of glaucoma.
Source: clinicaltrialsarena.com